Tick-Borne Encephalitis (TBE) Archives

FDA Gives Nod to Pfizer’s Tick-Borne Encephalitis Vaccine

Approvals, CDC, COVID-19 booster shots, Endemic, European Center for Disease Prevention and Control (ECDC), FDA, Pfizer, Tick-Borne Diseases, Tick-Borne Encephalitis (TBE)

The U.S. Food and Drug Administration approved Pfizer’s tick-borne encephalitis vaccine TICOVAC to prevent TBE in people aged 1 year and older.

August 16, 2021/by Andrew Humphreys

U.S. FDA Accepts for Priority Review Pfizer’s Application for TicoVac

Adults, Biologics License Application (BLA), Brain, Children, FDA, PDUFA, Pfizer, Priority Review Status, Spine, Tick-Borne Encephalitis (TBE), Ticks, Viral Infections

The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company’s tick-borne encephalitis vaccine for active immunization to prevent TBE in individuals 1 year of age and older.

February 23, 2021/by Andrew Humphreys